Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 3/20 | 0.44 |
| ▸ | ABL1 | P00519 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.44 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18359715 | 0.87 | CA1 (0.51) | HIF1AKDM4EPOLBABL1MAPT | |
| SCHEMBL19165160 | 0.81 | HIF1A (0.50) | HIF1AALDH1A1HSD17B10CYP1A2HPGD | |
| SCHEMBL3376374 | 0.79 | POLB (0.50) | KDM4EPOLBABL1MAPTRECQL | |
| SCHEMBL18359717 | 0.79 | HIF1A (0.43) | HIF1AKDM4EPOLBMAPTRECQL | |
| SCHEMBL5070398 | 0.79 | HIF1A (0.48) | HIF1AMAPTALDH1A1HSD17B10CYP1A2 | |
| SCHEMBL18359690 | 0.76 | HIF1A (0.46) | HIF1AALDH1A1HSD17B10CYP1A2HPGD | |
| SCHEMBL29953199 | 0.76 | MAPT (0.43) | HIF1AKDM4EMAPTRECQLALDH1A1 | |
| SCHEMBL19485050 | 0.75 | HIF1A (0.44) | HIF1AALDH1A1HSD17B10CYP1A2HPGD | |
| SCHEMBL18359705 | 0.75 | MAPT (0.44) | HIF1AKDM4EMAPTRECQLALDH1A1 | |
| SCHEMBL18359692 | 0.74 | ALDH1A1 (0.48) | HIF1AKDM4EMAPTALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10793482-B2 | Compounds and compositions for delivery of nutrients and micronutrients to plants | SPERO ENERGY, INC. (US) | 2020-10-06 | — | — | US | disclosed |
| US-20180208514-A1 | COMPOUNDS AND COMPOSITIONS FOR DELIVERY OF NUTRIENTS AND MICRONUTRIENTS TO PLANTS | SPERO ENERGY, INC. | 2018-07-26 | — | — | US | disclosed |
| US-20180208514-A1 | COMPOUNDS AND COMPOSITIONS FOR DELIVERY OF NUTRIENTS AND MICRONUTRIENTS TO PLANTS | SPERO ENERGY, INC. | 2018-07-26 | — | — | US | disclosed |
| WO-2017004052-A2 | COMPOUNDS AND COMPOSITIONS FOR DELIVERY OF NUTRIENTS AND MICRONUTRIENTS TO PLANTS | SPERO ENERGY, INC. (US) | 2017-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10793482-B2 | Compounds and compositions for delivery of nutrients and micronutrients to plants | SLC19A1, SLC19A2, SLC39A3 | HIF1A 1201/4885KDM4E 2970/4885POLB 3538/4885 |
| US-20180208514-A1 | COMPOUNDS AND COMPOSITIONS FOR DELIVERY OF NUTRIENTS AND MICRONUTRIENTS TO PLANTS | SLC19A1, SLC19A2, SLC39A3 | HIF1A 1201/4885KDM4E 2970/4885POLB 3538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.